COUGHLIN TIMOTHY 4
4 · aTYR PHARMA INC · Filed May 2, 2025
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
Coughlin Timothy P
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-01+50,000→ 50,000 totalExercise: $3.34Exp: 2035-05-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.